RSC Advances
Paper
Improved Pharmacokinetic Properties, ACS Med. Chem.
Lett., 2014, 5, 1162–1166; (c) Y. Zhu, J. Zhou and B. Jiao,
Deuterated Clopidogrel Analogues as a New Generation of
Antiplatelet Agents, ACS Med. Chem. Lett., 2013, 4, 349–352;
(d) A. Mullard, Deuterated drugs draw heavier backing,
Nat. Rev. Drug Discovery, 2016, 15, 219–221; (e) T. G. Gant,
Using Deuterium in Drug Discovery: Leaving the Label in
the Drug, J. Med. Chem., 2014, 57, 3595–3611.
Acknowledgements
We gratefully acknowledge National Natural Science Founda-
tion of China (NSFC) (21702028), Department of Science and
Technology of Jilin Province (20180520206JH), the Collaborative
Fund of Luzhou Government and Southwest Medical University
(2019LZXNYDJ16) and the Research Fund of Southwest Medical
University (2017-ZRQN-037) for nancial support.
5 (a) T. Junk and W. J. Catallo, Hydrogen isotope exchange
reactions involving C–H (D, T) bonds, Chem. Soc. Rev.,
1997, 26, 401–406; (b) Y. Sawama, Y. Monguchi and
H. Sajiki, Efficient H–D Exchange Reactions Using
Heterogeneous Platinum-Group Metal on Carbon–H2–D2O
System, Synlett, 2012, 23, 959–972; (c) J. Atzrodt, V. Derdau,
W. J. Kerr and M. Reid, CÀH Functionalisation for
Hydrogen Isotope Exchange, Angew. Chem., Int. Ed., 2018,
57, 3022–3047; (d) J. Atzrodt, V. Derdau, T. Fey and
J. Zimmermann, The Renaissance of H/D Exchange, Angew.
Chem., Int. Ed., 2007, 46, 7744–7765.
Notes and references
1 (a) J. Atzrodt and V. J. Derdau, Pd- and Pt-catalyzed H/D
exchange methods and their application for internal MS
standard preparation from a Sano-Aventis perspective, J.
Label. Compd. Radiopharm., 2010, 53, 674–685; (b)
A. Nakanishi, Y. Fukushima, N. Miyazawa, K. Yoshikawa,
T. Maeda and Y. J. Kurobayashi, Quantitation of
Rotundone in Grapefruit (Citrus paradisi) Peel and Juice by
Stable Isotope Dilution Assay, J. Agric. Food Chem., 2017,
65, 5026–5033; (c) E. Stokvis, H. Rosing and J. H. Beijnen,
Stable isotopically labeled internal standards in
quantitative bioanalysis using liquid chromatography/mass
spectrometry: necessity or not?, Rapid Commun. Mass
Spectrom., 2005, 19, 401–407; (d) C.-Y. Kao and R. W. Giese,
Measurement of N7-(2‘-Hydroxyethyl)guanine in Human
DNA by Gas Chromatography Electron Capture Mass
Spectrometry, Chem. Res. Toxicol., 2005, 18, 70–75.
6 (a) A. Martins and M. Lautens, A Simple, Cost-Effective
Method for the Regioselective Deuteration of Anilines, Org.
Lett., 2008, 10, 4351–4353; (b) S. Rasku, K. Whl,
J. Koskimies and T. Hase, Synthesis of isoavonoid
deuterium
labeled
polyphenolic
phytoestrogens,
Tetrahedron, 1999, 55, 3445–3454; (c) J. C. Seibles,
D. M. Bollinger and M. Orchin, Synthesis of
Perdeuteriobenzo[a]pyrene, Angew. Chem., Int. Ed. Engl.,
1977, 16, 656–657; (d) J. L. Garnett, M. A. Long,
R. F. W. Vining and T. Mole, New simple method for rapid,
selective aromatic deuteration using organoaluminum
dihalide catalysts, J. Am. Chem. Soc., 1972, 94, 5913–5914;
2 (a) E. M. Simmons and J. F. Hartwig, On the Interpretation of
Deuterium Kinetic Isotope Effects in CÀH Bond
Functionalizations by Transition-Metal Complexes, Angew.
Chem., Int. Ed., 2012, 51, 3066–3072; (b) T. Giagou and
M. P. Meyer, Kinetic Isotope Effects in Asymmetric
Reactions, Chem.–Eur. J., 2010, 16, 10616–10628.
¨¨
(e) M. Pohjoispaa, R. Mera-Adasme, D. Sundholm,
¨ ¨ ¨
S. Heikkinen, T. Hase and K. J. Wahala, Capricious
3 (a) E. M. Isin, C. S. Elmore, G. N. Nilsson, R. A. Thompson
and L. Weidolf, Use of Radiolabeled Compounds in Drug
Metabolism and Pharmacokinetic Studies, Chem. Res.
Toxicol., 2012, 25, 532–542; (b) P. Uhl, G. Fricker,
U. Haberkorn and W. Mier, Radionuclides in drug
development, Drug Discovery Today, 2015, 20, 198–208; (c)
A. E. Mutlib, Application of Stable Isotope-Labeled
Compounds in Metabolism and in Metabolism-Mediated
Toxicity Studies, Chem. Res. Toxicol., 2008, 21, 1672–1689;
(d) S. Nag, L. Lehmann, G. Kettschau, M. Toth,
T. Heinrich, A. Thiele, A. Varrone and C. Halldin,
Development of a novel uorine-18 labeled deuterated
uororasagiline ([18F]uororasagiline-D2) radioligand for
PET studies of monoamino oxidase B (MAO-B), Bioorg.
Med. Chem., 2013, 21, 6634–6641; (e) K. Y. Wong, Y. Xu and
L. Xu, Review of computer simulations of isotope effects on
biochemical reactions: from the Bigeleisen equation to
Feynman's path integral, Biochim. Biophys. Acta, Proteins
Proteomics, 2015, 1854, 1782–1794.
Selectivity in Electrophilic Deuteration of Methylenedioxy
Substituted Aromatic Compounds, Org. Chem., 2014, 79,
10636–10640.
7 (a) W. J. Kerr, D. M. Lindsay, M. Reid, J. Atzrodt, V. Derdau,
P. Rojahn and R. Weck, Iridium-catalysed ortho-H/D and -H/
T exchange under basic conditions: C–H activation of
unprotected tetrazoles, Chem. Commun., 2016, 52, 6669–
6672; (b) W. J. Kerr, M. Reid and T. Tuttle, Iridium-
Catalyzed C–H Activation and Deuteration of Primary
Sulfonamides: An Experimental and Computational Study,
ACS Catal., 2015, 5, 402–410; (c) B. McAuley, M. J. Hickey,
L. P. Kingston, J. R. Jones, W. J. S. Lockley, A. N. Mather,
E. Spink, S. P. Thompson and D. J. J. Wilkinson,
Convenient and efficient deuteration of functionalized
aromatics with deuterium oxide: catalysis by cycloocta-1,5-
dienyliridium(I) 1,3-dionates, J. Label. Compd. Radiopharm.,
2003, 46, 1191–1204; (d) D. Hesk, P. R. Das and B. J. Evans,
Deuteration of acetanilides and other substituted
aromatics using [Ir(COD)(Cy3P)(Py)]PF6 as catalyst, J. Label.
Compd. Radiopharm., 1995, 36, 497–502; (e) J. R. Heys,
A. Y. L. Shu, S. G. Senderoff and N. M. J. Phillips,
Deuterium exchange labelling of substituted aromatics
4 (a) A. Katsnelson, Heavy drugs draw heavy interest from
pharma backers, Nat. Med., 2013, 19, 656; (b) Y. Zhang,
M. D. Tortorella, Y. Wang, J. Liu, Z. Tu, X. Liu, Y. Bai,
D. Wen, X. Lu, Y. Lu and J. Talley, Synthesis of Deuterated
Benzopyran Derivatives as Selective COX-2 Inhibitors with
using
[IrH2(Me2CO)2(PPh3)2]BF4,
J.
Label.
Compd.
Radiopharm., 1993, 33, 431–438; (f) M. J. Hickey, J. R. Jones,
25478 | RSC Adv., 2020, 10, 25475–25479
This journal is © The Royal Society of Chemistry 2020